🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09073Q203 (prev. 09073Q105 )
- Market Cap
- Small Cap
- IPO
- 5/11/2015 · $5.00/share
- ADR Ratio
- 1:4000
- Previous Symbol
- BVXV (changed 8/23/2023)
- Previous Name
- BiondVax Pharmaceuticals Ltd.
Business: Scinai Immunotherapeutics Ltd. is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology biological products pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies.
Company Contact
- CEO
- Amir Reichman
- CFO
- Uri Ben Or
- Investor Relations
- joshua.phillipson@scinai.com